Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
85.37
-1.10 (-1.27%)
At close: Apr 28, 2026, 4:00 PM EDT
85.01
-0.36 (-0.42%)
After-hours: Apr 28, 2026, 4:15 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $6.29 billion as of April 28, 2026. Its market cap has increased by 261.78% in one year.
Market Cap
6.29B
Enterprise Value
5.50B
1-Year Change
261.78%
Ranking
Category
Stock Price
$85.37
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $6.29B, an increase of 677.84%. That is a compound annual growth rate of 108.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 6.39B | 25.36% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arcellx | 6.75B |
| Erasca | 6.68B |
| Protagonist Therapeutics | 6.38B |
| Belite Bio | 6.34B |
| Terns Pharmaceuticals | 6.11B |
| Centessa Pharmaceuticals | 6.10B |
| Spyre Therapeutics | 6.01B |
| Cogent Biosciences | 5.93B |